Speakers Bureau

Hematology/Oncology

Stuart E. Siegel, M.D. Professor and Vice Chair, Department of Pediatrics Keck School of Medicine of the University of Southern California Head, Division of Hematology/Oncology Director, Childrens Center for Cancer and Blood Diseases Childrens Hospital Los Angeles Presentations: Anemia in Childhood Aplastic Anemia Biological Markers in Pediatric Cancer: Their Use in Diagnosis and Prognosis Childhood Neuroblastoma - Clinical, Therapeutic and Experimental Results Childhood Thrombocyopenic Purpura Differences Between Cancers of Children and Adults Evaluation, Therapy and Prevention of Infectious Complications in the Cancer Patient Hematology in the Office Setting Hodgkins and Non-Hodgkins Lymphoma How are New Anti-Cancer Agents Developed? How Pediatric Cancer Research has Helped Adults with Cancer The Impact of Managed Care on pediatric Patient Management Improved Survival in Infants and Children with Primary Malignant Liver Tumors Iron Depletion and Iron Deficiency Anemia Late Effects of Childhood Cancer Limb Salvage in Children with Malignancies of the Extremities Long-Term Survivors of Childhood Cancer Lymphadenopathy in a Child The Management of Fever in Patients with Cancer Molecular Biology and its Impact on Cancer and Blood Disorders in Children Multidisciplinary Approach to Pediatric Bone Tumors Multidisciplinary Approach to the Cure of Cancer in Children New Agent Investigational Drug Trials in Childhood Cancer Patterns of Hodgkin's Disease at Diagnosis in Young Children Pediatric Oncology - Lessons from Recent Intergroup Studies Pediatric Solid Tumors - Results of Multidisciplinary Therapy Present Prognosis and Treatment of Childhood Leukemia Problems in the Chemotherapy of Cancer in the Neonate Recent Approaches to the Treatment of Acute Lymphocytic Leukemia in Childhood Retinoblastoma Treatment of Childhood Brain Tumors What's New With Anti-Cancer Drugs Wilms' Tumor - Diagnosis and Treatment Thomas D. Coates, M.D. Associate Professor of Pediatrics Keck School of Medicine of the University of Southern California Director, Red Cell/Hemoglobinopathy Program Section Head for Hematology Director, Hemophilia Treatment Center Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Anemia in Childhood Aplastic Anemia Bleeding Disorders Child with Recurrent Infections - Focus on Granulocytes Childhood Thrombocyopenic Purpura Chronic Granulomatous Disease DIC (Disseminated Intravascular Coagulation) Disorders of Granulocytes Evaluation of Neupiopenia in Children Hematology in the Office Setting Iron Overload The Management of the Acute Crises of Sickle Cell Anemia Neutroopenia in Children Preoperative Bleeding Studies and Their Significance Sickle Cell Disease Thalassemia Thrombophilia Von Willebrands Disease Cecilia H. Fu, M.D. Assistant Professor of Clinical Pediatrics Keck School of Medicine of the University of Southern California Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Pediatric Leukemias ITP Iron Deficiency Anemia Pediatric Oncology Paul S. Gaynon, M.D. Professor of Pediatrics Keck School of Medicine of the University of Southern California Director, Clinical Oncology Research Program Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Childhood Leukem Yves A. DeClerck, M.D. Professor of Pediatrics and Biochemistry and Molecular Biology Keck School of Medicine of the University of Southern California Vice President, Research Director, Research Institute Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Molecular Biology in Medicine Treatment Against Angiogenesis and Metastasis Pediatric Research at Childrens Hospital Los Angeles from Bench to Bedside Anna M. Butturini, M.D. Associate Professor of Clinical Pediatrics Keck School of Medicine of the University of Southern California Director, Adolescent Program Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Autologous Bone Marrow Transplantation for Pediatric Solid Tumors Biological Markers in Pediatric Cancer: Their Use in Diagnosis and Prognosis Biological Modifiers in Pediatric Oncology Diagnosis of Immunal Residual Disease Differences Between Cancers of Children and Adults Therapeutic Strategies for High Risk Pediatric Cancer What's New With Anti-Cancer Drugs Deborah G. Harris, P.N.P. Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Sickle Cell Disease Thalassemia Thomas C. Hofstra, M.D. Assistant Professor of Clinical Pediatrics Keck School of Medicine of the University of Southern California Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Blood Transfusions Thrombocytopenia Von Willebrands Disease When to Worry and When to Watch The Work-up and Evaluation of the Bleeding/Bruising Patient Controversies in the Diagnosis and Management of Disseminated Intravascular Coagolation Ernest R. Katz, Ph.D. Clinical Professor of Pediatrics and Psychology Keck School of Medicine of the University of Southern California and College of Letters, Arts & Sciences Director of Behavioral Sciences Section Childrens Center for Cancer and Blood Diseases Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Behavioral Assessment and Management of Pediatric Pain The Death of a Child Improving Coping in Parents of Chronically Ill Children Life-Threatening Illness - The Effect on Siblings Long-Term Survivors of Childhood Cancer Multidisciplinary Approach to the Cure of Cancer in Children Quality of Life in Children with Cancer and Their Families Special Concerns of Immigrant Hispanic Families with a Seriously Ill Child Teenagers with Cancer The Terminally-Ill Child - A Special Problem C. Patrick Reynolds, M.D., Ph.D. Head, Developmental Therapeutics Section Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Autologous Bone Marrow Transplantation for Pediatric Solid Tumors Childhood Neuroblastoma - Clinical, Therapeutic and Experimental Results Laboratory Development of Drugs for Childhood Cancer Molecular Biology and its Impact on Cancer and Blood Disorders in Children New Agent Investigational Drug Trials in Childhood Cancer Retinoids in Cancer Therapy Myra D. Saltoun-Moran, Ph.D. Program Director, Padres Contra El Cancer Staff Psychologist, Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Cultural Issues in Treating the Latino Child with Cancer Teenagers with Cancer Judith G. Villablanca, M.D. Assistant Professor of Clinical Pediatrics Keck School of Medicine of the University of Southern California Clinical Director, Neuroblastoma Program Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Autologous Bone Marrow Transplantation for Pediatric Solid Tumors Childhood Neuroblastoma - Clinical, Therapeutic and Experimental Results Neuroblastoma - Current Approach to Treatment Retinoblastoma - Current Treatment Approaches Retinoids - Uses in Cancer Therapy Treatment of Childhood Brain Tumors Workshop of Abdominal Masses in Children Wing-Yen Wong, M.D. Assistant Professor of Pediatrics Keck School of Medicine of the University of Southern California Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Anemia in Childhood Bleeding Disorders in Neonates and Children Blood Transfusions Childhood Thrombocytopenic Purpura Concepts in the Diagnosis and Management of Hemophilia and Related Disorders Evaluation and Management of Disorders of Platelet Function Gene Therapy in Hemophilia Genetic Aspects of Inherited Bleeding Disorders Hematology in the Office Setting Hemostasis Problems and Chronic Disease Hepatitis in Children with Hemophilia Immune Hemolytic Anemia The Management of Hemophilia The Management of the Acute Crises of Sickle Cell Anemia Neutroopenia in Children Sickle Cell Disease Thrombiphilia - Clotting Disorders Thrombocytopenia Use of Blood and Blood Products Von Willebrands Disease Guy Young, M.D. Associate Professor of Clinical Pediatrics Keck School of Medicine of the University of Southern California Division of Hematology/Oncology Childrens Hospital Los Angeles Presentations: Experimental uses of recombinant factor VIIa Success in hemophilia: Determining the right treatment regimen The new coagulation cascade Prothrombin gene mutation and the use of direct thrombin inhibitors in children Current concepts in coagulation theory Novel hemostatic agents Management and monitoring of bleeding in hemophilia patients with inhibitors Direct thrombin inhibitors in children Novel anticoagulants in children Thrombosis in the Intensive Care Unit Novel anticoagulants in children HIV-associated thrombocytopenia Overview of sickle cell anemia Update on the management of thrombosis in children Update on the management of thrombosis Management of excessive bleeding What's new in Hemostasis Thrombosis in children Approach to the diagnosis of anemia in children Rare factor deficiencies A new way of thinking about the coagulation cascade The management of bleeding and thrombotic complications in pediatric oncology patients Diagnosis and management of bleeding disorders in children New approaches to hemostasis in surgery Head trauma in hemophilia Prevention of chronic joint disease in hemophilia Heparin-induced thrombocytopenia in children Prophylaxis in hemophilia Coagulation disorders in children Immune tolerance therapy Treatment of bleeding episodes Joint health and pain management

Return to menu